CYP2C9Your two copies: *1/*2
Intermediate metabolizer
One copy works and one works less well.
1.5 activity scoreTypical: 2Clears warfarin, phenytoin, celecoxib and some other pain relievers.
This result doesn't change the label.
Example report. Made from Leslie Knope's DNA data so you can see what yours will look like. Get your own report
Pain managementExample report
Lornoxicam
Xefo
Use as directed
Your body slows the drug down slightly, but usually the normal starting dose is fine.
The genes behind this label
The guidelines read one gene for lornoxicam. Each card shows the two copies this person inherited and what they mean.
What the guidelines say
What each guideline says about your result.
CYP2C9Intermediate metabolizer (activity score 1.5)
CPIC guideline
Evidence: moderateRead the guideline (Clinical Pharmacogenetics Implementation Consortium, opens in a new tab)
- In plain words
- Your body slows the drug down slightly, but usually the normal starting dose is fine.
- What it means
- Mildly reduced metabolism
- What the guideline suggests
- Initiate therapy with recommended starting dose. In accordance with the prescribing information, use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.
About lornoxicam
Lornoxicam (Xefo) is a nonsteroidal anti-inflammatory drug (NSAID) authorised in a number of European countries for short-term relief of mild to moderate pain and for osteoarthritis and rheumatoid arthritis.
- Used for
- Short-term relief of acute mild to moderate pain; pain and inflammation in osteoarthritis and rheumatoid arthritis
Others in pain management
Compare all 13 pain managementDon't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.